Compare Stocks

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$0.86 -7.6%	$1.19	$0.85 ▼ $2.55	$1.84B	1.35	23.52 million shs	38.88 million shs
KOR Corvus Gold	$3.21	$3.23	$1.71 ▼ $3.30	$407.68M	N/A	174,024 shs	14,560 shs
MAX MediaAlpha	$19.02 +2.5%	$19.28	$5.08 ▼ $22.81	$1.25B	1.35	288,833 shs	215,046 shs
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	$49.41	$49.41	$37.71 ▼ $54.66	$5.44M	N/A	314 shs	N/A
VIT VanceInfo Technologies		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	81,901 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	+6.20%	-11.94%	-14.78%	-23.90%	-29.95%
KOR Corvus Gold	0.00%	0.00%	0.00%	0.00%	-0.62%
MAX MediaAlpha	+2.43%	-7.80%	-4.13%	+70.97%	+95.68%
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	0.00%	0.00%	0.00%	0.00%	-6.60%
VIT VanceInfo Technologies	0.00%	0.00%	0.00%	0.00%	0.00%

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DNA Ginkgo Bioworks	1.2611 of 5 stars	3.0	0.0	0.0	0.0	2.3	3.3	0.6
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	1.2656 of 5 stars	1.3	4.0	0.0	0.0	3.3	3.3	0.6
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNA Ginkgo Bioworks	2.00	Hold	$2.20	157.07% Upside
KOR Corvus Gold	N/A	N/A	N/A	N/A
MAX MediaAlpha	2.67	Moderate Buy	$18.20	-4.31% Downside
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	0.00	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest VIT, PGM, KOR, MAX, and DNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/1/2024	DNA Ginkgo Bioworks	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$7.00 ➝ $3.00
2/26/2024	MAX MediaAlpha	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$9.00 ➝ $28.00
2/21/2024	MAX MediaAlpha	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$12.00 ➝ $18.00
2/21/2024	MAX MediaAlpha	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$18.00 ➝ $22.00
1/22/2024	DNA Ginkgo Bioworks	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sell ➝ Sell	$1.25 ➝ $1.10

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNA Ginkgo Bioworks	$251.46M	7.33	N/A	N/A	$0.55 per share	1.56
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	$388.15M	3.23	N/A	N/A	($1.44) per share	-13.21
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A	N/A	N/A	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNA Ginkgo Bioworks	-$892.87M	-$0.47	N/A	N/A	N/A	-355.08%	-48.23%	-31.35%	5/8/2024 (Estimated)
KOR Corvus Gold	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	-$40.42M	-$0.89	N/A	N/A	N/A	-10.41%	N/A	-27.85%	5/1/2024 (Confirmed)
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest VIT, PGM, KOR, MAX, and DNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2024	N/A	MAX MediaAlpha	-$0.11	N/A	+$0.11	N/A	N/A	N/A
2/29/2024	12/31/2023	DNA Ginkgo Bioworks	-$0.09	-$0.10	-$0.01	-$0.07	$40.37 million	$34.76 million
2/20/2024	Q4 2023	MAX MediaAlpha	-$0.21	-$0.05	+$0.16	-$0.05	$111.36 million	$117.17 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	N/A	N/A	N/A	N/A	N/A
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A	N/A	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNA Ginkgo Bioworks	N/A	6.11	6.11
KOR Corvus Gold	N/A	N/A	N/A
MAX MediaAlpha	N/A	0.94	0.94
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A	N/A	N/A
VIT VanceInfo Technologies	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DNA Ginkgo Bioworks	78.63%
KOR Corvus Gold	N/A
MAX MediaAlpha	64.39%
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A
VIT VanceInfo Technologies	N/A

Insider Ownership

Company	Insider Ownership
DNA Ginkgo Bioworks	15.05%
KOR Corvus Gold	N/A
MAX MediaAlpha	11.53%
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	N/A
VIT VanceInfo Technologies	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DNA Ginkgo Bioworks	1,218	2.15 billion	1.83 billion	Optionable
KOR Corvus Gold	N/A	127.00 million	N/A	Not Optionable
MAX MediaAlpha	137	65.82 million	58.23 million	Not Optionable
PGM iPath Series B Bloomberg Platinum Subindex Total Return ETN	2,020	110,000	N/A	Not Optionable
VIT VanceInfo Technologies	N/A	N/A	N/A	Not Optionable

VIT, PGM, KOR, MAX, and DNA Headlines

Source	Headline
	Top 8 Best Vitamin E Supplement in 2024 straight.com - April 16 at 7:16 PM
	Verified & Tested The Vitamin Shoppe Coupons & Codes washingtonpost.com - April 7 at 9:19 PM
	Top 6 Best Vitamin C and Zinc Supplement in 2024 straight.com - March 26 at 12:40 AM
	Top 6 Best Vitamin B2 Supplements in 2024 straight.com - March 25 at 3:35 AM
	Top 8 Best Vitamin Packs for Men in 2024 straight.com - March 22 at 11:35 PM
	Best Vitamin C Serum cnet.com - February 7 at 3:32 PM
	The Benefits of Vitamin C webmd.com - January 18 at 10:38 PM
	Top 6 Best Calcium Supplements Without Vitamin D in 2024 straight.com - January 7 at 2:10 AM
	Taking Vitamin D and Calcium Together webmd.com - January 1 at 6:34 PM
	Vitamin Deficiency: Common Symptoms to Watch For health.usnews.com - December 28 at 8:10 AM
	Vitamin A news-medical.net - December 21 at 6:25 AM
	Top 8 Best Calcium and Vitamin D Supplements in 2023 straight.com - December 18 at 7:35 PM
	The Mystery of Vitamin C nature.com - December 11 at 3:06 PM
	8 Benefits of Vitamin D—and How to Get More in Your Diet health.com - December 6 at 6:12 PM
	Why Vitamin D is important for runners runnersworld.com - December 4 at 3:48 PM
	The Vitamin Shoppe Coupons time.com - November 29 at 2:54 PM
	Vitamin E Supplementation: What to Do? medscape.com - November 25 at 9:47 AM
	Vitamin D deficiency: key signs that you’re not getting enough standard.co.uk - November 18 at 7:01 PM
	20 Foods High in Vitamin A and How to Eat More of Them prevention.com - September 25 at 6:16 PM
	Prenatal Vit No.95-Ferrous Fumarate 28 Mg-Folic Acid 800 Mcg Tablet - Uses, Side Effects, and More webmd.com - September 21 at 7:13 PM
	Nine warning signs of vitamin D deficiency that you may not know about liverpoolecho.co.uk - September 17 at 2:53 PM
	Vitamin B News sciencedaily.com - September 2 at 11:02 PM
	Vitamin E News sciencedaily.com - August 17 at 9:53 AM
	Vitamin D News sciencedaily.com - August 11 at 12:53 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Stocks With Unusual Call Option Activity
March 26, 2024 1:10 PM
View 3 Stocks With Unusual Call Option Activity
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Delta Airline’s Put Option Activity Isn’t Bad News
March 28, 2024 8:55 AM
View Delta Airline’s Put Option Activity Isn’t Bad News
3 Most Active Penny Stocks: Buy, Sell, or Hold
April 4, 2024 9:25 AM
View 3 Most Active Penny Stocks: Buy, Sell, or Hold
Michael Burry Picked a Winner With GEN Restaurant Group
April 2, 2024 7:09 AM
View Michael Burry Picked a Winner With GEN Restaurant Group

All Headlines

Company Descriptions

Ginkgo Bioworks

NYSE:DNA

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Corvus Gold

NYSE:KOR

Corvus Gold is a junior exploration and development gold company led by an experienced management team that holds a large equity stake. The Company's main focus and efforts is in the advancement of its 100% owned North Bullfrog project - a new Nevada gold discovery.

MediaAlpha

NYSE:MAX

MediaAlpha, Inc., through its subsidiaries, operates an insurance customer acquisition platform in the United States. It optimizes customer acquisition in various verticals of property and casualty insurance, health insurance, and life insurance. The company was founded in 2014 and is headquartered in Los Angeles, California.

iPath Series B Bloomberg Platinum Subindex Total Return ETN

NYSEARCA:PGM

VanceInfo Technologies

NYSE:VIT

VanceInfo Technologies Inc. (VanceInfo) is a holding company. VanceInfo is an information technology (IT) service provider and is offshore software development company. VanceInfo is principally engaged in the provision of IT services, which include quality assurance testing, application development and maintenances (ADMs), research and development (R&D), globalization and localization, and enterprise solutions in the People's Republic of China. It categorizes its services into three sets: R&D Outsourcing Services, IT Services, and other solutions and services. In February 2012, it acquired 100% interest in Beijing Sunwin Technology Co., Ltd., and 50% interest in Beijing Yunxiang Weiye Information Technology Co., Ltd. In October 2011, the Company acquired the assets and the professional team of the United Sates-based IT services company. On August 1, 2011, it acquired 100% interest in Beijing Data Pioneer Information Technology Co., Ltd.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial